Lantheus Holdings Inc
NASDAQ:LNTH
Lantheus Holdings Inc
Revenue
Lantheus Holdings Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Revenue
$1.3B
|
CAGR 3-Years
56%
|
CAGR 5-Years
30%
|
CAGR 10-Years
16%
|
|
Haemonetics Corp
NYSE:HAE
|
Revenue
$1.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Cooper Companies Inc
NYSE:COO
|
Revenue
$3.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Revenue
$4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Revenue
$3.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
19%
|
Lantheus Holdings Inc
Revenue Breakdown
Breakdown by Geography
Lantheus Holdings Inc
Breakdown by Segments
Lantheus Holdings Inc
Total Revenue:
1.3B
USD
|
Product:
1.3B
USD
|
Radiopharmaceutical Oncology:
854.4m
USD
|
Pylarify:
851.3m
USD
|
Total Precision Diagnostics:
390.1m
USD
|
Definity:
279.8m
USD
|
Techne Lite:
87.4m
USD
|
Strategic Partnerships And Other:
51.9m
USD
|
License And Royalty Revenues:
33.4m
USD
|
Other Precision Diagnostics:
23m
USD
|
Other Radiopharmaceutical Oncology:
3.1m
USD
|
See Also
What is Lantheus Holdings Inc's Revenue?
Revenue
1.3B
USD
Based on the financial report for Dec 31, 2023, Lantheus Holdings Inc's Revenue amounts to 1.3B USD.
What is Lantheus Holdings Inc's Revenue growth rate?
Revenue CAGR 10Y
16%
Over the last year, the Revenue growth was 39%. The average annual Revenue growth rates for Lantheus Holdings Inc have been 56% over the past three years , 30% over the past five years , and 16% over the past ten years .